2000 (10 POSTS)

Clewell HJ III, Gentry PR, Allen BC, Covington TR, Gearhart JM. 2000. Development of a physiologically-based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment. Environ Health Perspect 108(Suppl 2):283–305.

View Abstract

Gentry R, Clewell H, Covington T, Wilson J. Investigation of the impact of Benchmark and PBPK modeling on the derivation of MRLs. Poster presented at the Society of Toxicology Annual Meeting, Philadelphia, PA, March 2000.

Clewell HJ, Gentry PR, Gearhart JM, Born SL, Lehman-McKeeman LD, Covington TR. Development of a physiologically-based pharmacokinetic (PB-PK) model and human health risk assessment for coumarin.  Poster presented at the Society of Toxicology Annual Meeting, Philadelphia, PA, March 2000.

Choksi NY, Nix WB, Wyrick SD, Booth RG. 2000. A novel phenylaminotetralin (PAT) recognizes histamine H1 receptors and stimulates dopamine synthesis in vivo in rat brain. Brain Research 852:151–160, DOI: 10.1016/s0006-8993(99)02228-3.

View Abstract

1999 (11 POSTS)

Liu L, Engvall E. 1999. Sarcoglycan isoforms in skeletal muscle. J Biol Chem 274(53):38171–38176.

View Abstract

Choksi NY, Nix WB, Wyrick SD, Booth RG. Phenylaminotetralins activate histamine H1 receptors to stimulate dopamine synthesis in vivo in rat brain. Poster presented at the Receptor Chemistry Towards the Third Millennium – 12th Camerino-Noordwijkerhout Symposium, 1999.

Clewell HJ, Gearhart JM, Gentry PR, Covington TR, Van Landingham CB, Crump KS, and Shipp AM. 1999. Evaluation of the uncertainty in an oral reference dose for methylmercury due to interindividual variability in pharmacokinetics. Risk Anal 19:541–552.

View Abstract

Rish W, Kirman CR, Hays SM, Gargas ML, Andersen ME, Reitz RH, Guengerich FP, Green T, McConnell EE, Buckpit A, Voytek P, Dugard PH. 1999. Developing a physiologically based pharmacokinetic model to describe methylene chloride kinetics at the subcellular level. Toxicologist 48, Paper No. 671. Presented at the 38th Annual Meeting of the Society of Toxicology, New Orleans, LA.

Zucker RM, Hunter ES III, Rogers JM. 1999. Apoptosis and morphology in mouse embryos by confocal laser scanning microscopy. Methods 18: 473–480.

View Abstract

Parvathy S, Choksi N, Fang Y, Sabo SL, Buxbaum JD. Characterization of multipartite complexes of APP. Poster presented at Society for Neuroscience Annual Meeting, 1999

View Abstract

Lilliehook C, Choksi NY, Hof P, Choi EK, Zaidi NF, Wasco W, et al. Characterization of the presenilin-binding protein calsenilin. Poster presented at Society for Neuroscience Annual Meeting, 1999

View Abstract

Fang Y, Choksi NY, Parvathy S, Yamin JJ, Wasco W, Buxbaum JD. Proteins interacting with the COOH-termini of the presenilins. Poster presented at Society for Neuroscience Annual Meeting, 1999.

View Abstract

Choksi NY, Mukherjeree P, Lindroth A, Xiang Z, Wasco W, Buxbaum JD, Pasinetti GM.  Cyclooxygenase (COX)-2 expression is associated with presenilin-2 induced apoptosis. Poster presented at Society for Neuroscience Annual Meeting, 1999

Gentry R, Clewell H, Gearhart J, Covington T, Andersen M. Development of a physiologically-based pharmacokinetic (PB-PK) model for isopropanol and acetone. Poster presented at the Society of Toxicology Annual Meeting, New Orleans, LA, March 1999.

Bogdanffy MS, Keller DA. 1999. Metabolism of xenobiotics by the respiratory tract. In: Gardener, DE (ed), Toxicology of the Lung, 3rd ed., pp. 85–124. Taylor and Francis, Philadelphia, PA.

1998 (10 POSTS)

Kodavanti PR, Derr-Yellin EC, Mundy WR, Shafer TJ, Herr DW Barone S, Choksi, NY, MacPhail RC, Tilson HA. 1998. Repeated exposure of Aroclor 1254 causes brain region-specific changes in intracellular Ca2+ buffering and protein kinase C activity in the absence of changes in tyrosine hydroxylase. Toxicol Appl Pharmacol 153:186–198, DOI: 10.1006/taap.1998.8533.

View Abstract

Kuang W, Xu H, Vachon HP, Liu L, Loechel F, Wewer UM, Engvall E. 1998. Merosin-deficient congenital muscular dystrophy; partial genetic correction in two mouse models. J Clin Invest 102(4):844–852.

View Abstract

Rogers JM. 1998. Life stage and its impact on risk of environmentally-induced adverse effects: Introduction. Environ Toxicol Pharmacol 4:299–300.

Keen CL Taubeneck, MW Zidenberg, Cherr S, Daston GP, Rogers JM. 1998. Toxicant exposure and trace element metabolism in pregnancy. Environ Toxicol Pharmacol 4:301–308.

View Abstract

Zucker RM, Hunter S, Rogers JM. 1998. Confocal laser scanning microscopy of apoptosis in organogenesis-stage mouse embryos. Cytometry 33:348–354.

View Abstract